 DUBLIN, Ireland, Nov. 22, 2022 GLOBE NEWSWIRE -- Avadel Pharmaceuticals plc Nasdaq: AVDL, a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: 